Dicerna Pharma (DRNA)

12.71 -0.03 (0.24%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (3/8/19 *Est.)

Latest Headlines

Dicerna to Participate in Citi’s 2018 Global Healthcare Conference November 29, 2018 7:30 AM - BizWire Leerink Partners Starts Dicerna Pharmaceuticals (DRNA) at Outperform November 27, 2018 4:16 PM - StreetInsider Form 4 Dicerna Pharmaceuticals For: Nov 07 Filed by: Kolchinsky Peter November 9, 2018 4:31 PM - SEC Filing Dicerna to Highlight Lead GalXC™ Pipeline Programs, Collaborations, and Advances to GalXC Technology Platform at R&D Day 2018 November 9, 2018 8:00 AM - BizWire Form 10-Q/A Dicerna Pharmaceuticals For: Sep 30 November 7, 2018 5:15 PM - SEC Filing Form SC 13D/A Dicerna Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC November 7, 2018 6:14 AM - SEC Filing Form 4 Dicerna Pharmaceuticals For: Nov 02 Filed by: Kolchinsky Peter November 6, 2018 6:22 PM - SEC Filing Form 4 Dicerna Pharmaceuticals For: Nov 02 Filed by: Halak Brian K November 6, 2018 4:18 PM - SEC Filing Dicerna to Participate in Upcoming Investor Conferences November 6, 2018 7:30 AM - BizWire B.Riley/FBR Upgrades Dicerna Pharmaceuticals (DRNA) to Buy November 6, 2018 3:36 AM - StreetInsider Form 10-Q Dicerna Pharmaceuticals For: Sep 30 November 5, 2018 4:46 PM - SEC Filing Dicerna Pharma (DRNA) Misses Q3 EPS by 10c November 5, 2018 4:41 PM - StreetInsider Form 8-K Dicerna Pharmaceuticals For: Nov 05 November 5, 2018 4:19 PM - SEC Filing Dicerna Reports Third Quarter 2018 Financial and Operating Results and Provides Corporate Update November 5, 2018 4:05 PM - BizWire Form SC 13D/A Dicerna Pharmaceuticals Filed by: Domain Partners VIII, L.P. November 5, 2018 10:31 AM - SEC Filing Form 4/A Dicerna Pharmaceuticals For: Oct 30 Filed by: Halak Brian K November 5, 2018 10:07 AM - SEC Filing Form SC 13D/A Dicerna Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC November 2, 2018 6:05 AM - SEC Filing Form 4 Dicerna Pharmaceuticals For: Oct 30 Filed by: Kolchinsky Peter November 1, 2018 7:45 PM - SEC Filing Form 4 Dicerna Pharmaceuticals For: Oct 30 Filed by: Halak Brian K November 1, 2018 6:09 PM - SEC Filing Dicerna to Report Third Quarter 2018 Financial Results and Host Conference Call on November 5, 2018 October 30, 2018 7:30 AM - BizWire Dicerna Pharmaceuticals (DRNA) PT Raised to $30 at Citi October 29, 2018 11:31 AM - StreetInsider Pre-Open Stock Movers 10/29: (RHT) (DRNA) (ON) Higher; (DNR) (FDC) (IBM) Lower (more...) October 29, 2018 9:29 AM - StreetInsider Form 8-K Dicerna Pharmaceuticals For: Oct 25 October 29, 2018 6:19 AM - SEC Filing Eli Lilly & Co. (LLY) Reports RNAi Licensing & Research Collaboration with Dicerna Pharmaceuticals (DRNA) October 29, 2018 6:13 AM - StreetInsider Lilly and Dicerna Announce RNAi Licensing and Research Collaboration October 29, 2018 6:00 AM - PR NewsWire Dicerna Pharma (DRNA) Highlights Late-Breaking Data Supporting Use of DCR-PHXC in Adults with Primary Hyperoxaluria Types 1 and 2 (PH1 and PH2) October 25, 2018 1:21 PM - StreetInsider Dicerna Announces Late-Breaking Data Supporting Use of DCR-PHXC in Adults with Primary Hyperoxaluria Types 1 and 2 (PH1 and PH2) October 25, 2018 1:00 PM - BizWire Alexion Pharmaceuticals, Inc. (ALXN), Dicerna Pharma (DRNA) Report Collaboration to Discover and Develop RNAi Therapies for Complement-Mediated Diseases October 24, 2018 6:42 AM - StreetInsider Form 8-K Dicerna Pharmaceuticals For: Oct 22 October 24, 2018 6:32 AM - SEC Filing Alexion and Dicerna Announce Collaboration to Discover and Develop RNAi Therapies for Complement-Mediated Diseases October 24, 2018 6:30 AM - BizWire New Research Coverage Highlights MEDIFAST INC, Palo Alto Networks, Salesforce, Agile Therapeutics, Dicerna Pharmaceuticals, and Corbus Pharmaceuticals — Consolidated Revenues, Company Growth, and Ex October 23, 2018 8:25 AM - Globe NewsWire Dicerna Announces Late-Breaking Data from the PHYOX Phase 1 Clinical Trial of DCR-PHXC Will Be Presented at ASN Kidney Week 2018 October 5, 2018 12:54 PM - BizWire Dicerna Pharma (DRNA) Added to Citi Catalyst Watch List September 24, 2018 5:07 PM - StreetInsider Dicerna to Participate in Two Upcoming Investor Conferences September 24, 2018 7:30 AM - BizWire Form CT ORDER Dicerna Pharmaceuticals September 13, 2018 9:58 AM - SEC Filing Dicerna Pharmaceuticals (DRNA) PT Lowered to $20 at H.C. Wainwright on Dilution September 13, 2018 7:16 AM - StreetInsider Citi Starts Dicerna Pharmaceuticals (DRNA) at Buy September 13, 2018 6:00 AM - StreetInsider Form 8-K Dicerna Pharmaceuticals For: Sep 06 September 11, 2018 5:29 PM - SEC Filing Full Article List